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02 The Journal of Thoracic and Cardioackground: Surgical case-mix is seriously worsening, and the results of surgical
evascularization on high-risk cohorts should be continuously evaluated. This study
nvestigates the influence of diabetes mellitus on the short and midterm outcome in
he modern era of coronary surgery.
ethods and Results: Patients who underwent first-time coronary artery bypass
rafting from April 1996 to October 2003 were classified into diabetic and nondi-
betic groups. Data were prospectively collected and retrospectively analyzed. A
otal of 5259 patients were studied, and of these 877 (17%) were diabetic. Patients
ith diabetes were more likely to be female, have a higher body mass index, be in
n advanced New York Heart Association class and Canadian Cardiovascular
ociety class, have a history of congestive heart failure, have a poor ejection
raction, renal failure, and more extensive coronary artery disease than the nondi-
betic group (P  .001 for all). In-hospital mortality was 2.2% and 1% for diabetic
nd nondiabetic patients, respectively; however, diabetes was not found to be an
ndependent risk factor for in-hospital mortality (odds ratio 1.63; 95% confidence
nterval 0.92-2.88; P  .089). Postoperative complications were comparable in the
wo groups, with only renal, neurologic, and gastrointestinal complications signif-
cantly associated with diabetes (all P  .05). There was no association between
iabetes mellitus and postoperative infective complications. Diabetes remained an
ndependent predictor of 5-year mortality (hazard ratio 1.55; 95% confidence
nterval 1.22-1.96; P  .001) and of lower 5-year cardiac-related event-free
urvival.
onclusion: Despite a worsening cohort, diabetic patients could be surgically
evascularized with low morbidity and mortality, comparable with control patients.
he negative effect of diabetes mellitus on the longer-term mortality and morbidity
emains a problem.
iabetes has been recognized as a major risk factor for atherosclerosis,1,2 and
its prevalence is on the rise owing to an increasingly aged and obese
population.3 Currently, patients with diabetes mellitus represent about 2
f patients undergoing coronary artery bypass graft (CABG) surgery,4-6 and in th
ast diabetes has been associated with increased in-hospital morbidity and mortal-
ty.7-9 Over the years, reports have maintained the superiority of CABG surgery
ercutaneous coronary intervention as the preferred method of coronary revascu-
arization in diabetic patients.10-13 In the past decade, however, there has bee
ignificant worsening of the risk profile of surgical patients,14 o whom the resul
f previous studies cannot be uncritically applied. In our own institution, the
arsonnet risk score increased from a median of 4 (interquartile range 2-8) in 1996
o 6 (interquartile range 3-11) in 2002 (P  .001), the percentage of patients with
iabetes has risen from 15% in 1996 to 20% of patients treated in 2002, and the
urgical population is aging. In 1996, 39% of patients were over 65 years; by 2002
vascular Surgery ● October 2006
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CDhis had risen to 49% of patients. Hence, there is a need to
pdate continuously the performance of surgical revascu-
arization in diabetic patients.
The aim of this study was to investigate the effect of
iabetes mellitus on in-hospital and midterm clinical out-
omes in patients operated on in the current era of CABG
urgery.
ethods
atient Selection
standard set of perioperative data are collected prospectively for
ll patients undergoing cardiac surgery at our institution. The data
et comprises 5 sections to be filled in consecutively by anesthetist,
urgeon, cardiac intensive care unit, high-dependency unit, and
ard nurses. Data are entered into the Patient Analysis and Track-
ng Systems Database (Dentrite Clinical Systems, London, United
ingdom). All adults who underwent first-time CABG surgery at
ur institution from April 1996 to October 2003 were included.
atients having redo operations, any concomitant surgery, and
urgery as a salvage procedure were excluded from the analysis.
nesthetic and Surgical Management
nesthetic and surgical techniques were as reported previousl15
or conventional CABG operations, a standard cardiopulmonary
ypass circuit was used and systemic temperature was maintained
etween 34°C and 36°C. Myocardial protection was achieved with
ntermittent antegrade warm blood cardioplegia. For off-pump
oronary artery bypass (OPCAB) procedures, the technique was as
reviously reported,16 and its use was based on surgeon pre-
nce. At the end of surgery, patients were transferred to the
ardiac intensive care unit and were extubated as soon as they
et the following criteria: hemodynamic stability, no excessive
leeding (80 mL/h), normothermia, and consciousness with
ain control.
anagement of Medication
reoperative medications, including antidiabetic agents, statins,
-blockers, diuretics, antihypertensives, and calcium channel
lockers, were routinely omitted on the day of surgery. Aspirin
as omitted 3 days before surgery. Angiotensin-converting en-
yme inhibitors were withdrawn on the evening before the oper-
tion. Aspirin (300 mg) was given 4 hours after the operation if
hest tube drainage was less than 100 mL/h and decreasing. On the
rst postoperative day, all patients began receiving enoxaparin (20
Abbreviations and Acronyms
CABG  coronary artery bypass graft
CI  confidence interval
HR  hazard ratio
NSTS  National Health Service Strategic Tracing
Service
OPCAB off-pump coronary artery bypass
OR  odds ratiog), which was stopped at discharge, and aspirin (300 mg), which w
The Journal of Thoracicas reduced to 75 mg after 3 months. On day 1, statins, -blockers,
iuretics, antihypertensives, and angiotensin-converting enzyme
nhibitors were all restarted, according to a standard unit protocol,
hich is based on accurate monitoring of blood pressure and renal
unction. After discharge, these drugs are prescribed and moni-
ored by the family physician and through routine visits to the
ardiology department outpatient clinic.
At our institution we aim to maintain the blood glucose levels
n diabetic patients between 5 and 8 mmol/L. Preoperatively,
iabetic patients are started on a standard sliding scale insulin
nfusion, which is maintained for the first 48 hours postoperatively.
hey are then switched to their baseline antidiabetic medications,
hich are reviewed by a diabetologist until discharge and managed
y the family physician, with regular visit to the diabetes outpa-
ient clinic, after discharge. For nondiabetic patients, the use of
liding scale insulin infusion is triggered by blood glucose levels
reater than 10 mmol/L.
ata Collection, Monitoring, Follow-up,
nd Definitions
atients were considered to be diabetic on the basis of history,
egardless of duration of disease and need for diabetic medications.
erioperative death was defined as any death occurring in the
ospital (ie, in patients who had not been discharged after the
peration). In-hospital complications were recorded and defined as
reviously reported.15,17
Information about the vital status was obtained from the Na-
ional Health Service Strategic Tracing Service (NSTS). Follow-up
ith respect to cardiac-related events was by a standard question-
aire to the patient and to the patient’s family physician, as
reviously reported.18 Nonfatal cardiac-related events included t
ollowing: (1) the need for a further coronary revascularization
rocedure (whether reoperation or percutaneous transluminal cor-
nary angioplasty), (2) patient-reported hospital attendance for
yocardial infarction or recurrent angina, or (3) report of cardiac-
elated hospital admission by the patient or the family physician. In
nalyses of patient and cardiac event-free survival, patients who
ad not experienced an event were censored at the date of last
ollow-up.
tatistical Analysis
aseline and operative characteristics were compared with a 2 or
isher exact test (categorical variables) or the Mann-Whitney test
continuous variables). Outcomes for the respective diabetic and
ondiabetic subgroups were compared both with and without
djusting for possible confounding, using logistic or Cox regres-
ion (Stata version 8.2; Stata Corporation, College Station, Tex),
epending on whether the outcome was a binary or a time-to-event
ariable. Variables included in the adjusted analyses were chosen
ecause they showed imbalance between the two groups and/or
hey were thought to affect the outcome. The same variables were
ncluded in all the risk-adjusted analyses presented (see Tab
ootnote for details). Some potential confounders (eg, age and
ody mass index) were dichotomized. Model assumptions were
hecked and, where untenable, alternative models were explored.
he number of prognostic variables and outcomes of interest
esulted in a large number of statistical comparisons. No correction
as made for multiple comparisons, but confidence intervals and
and Cardiovascular Surgery ● Volume 132, Number 4 803
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A
CDxact P values are presented throughout. The interpretation of the
ndings takes into account the consistency of the findings and their
agnitude, as well as their statistical significance.
esults
ata on 5259 consecutive patients undergoing first-time
ABG surgery were collected prospectively. Of these, 877
17%) were treated diabetics. The distribution of baseline
haracteristics between the two groups is shown in Tab
iabetic patients were more likely to be female, have a
igher body mass index, be in an advanced NYHA and CCS
lass, have a history of congestive heart failure and myo-
ardial infarction, be hypertensive, have an ejection fraction
ess than 50%, and have more extensive coronary artery
isease than the nondiabetic patients (all P  .001).
The distribution of operative variables and postoperative
utcomes is shown in Table 2. Similar percentages of
ients in the two groups were revascularized without the use
f cardiopulmonary bypass and underwent complete coronary
evascularization (33.5% vs 31.3% and 75.9% vs 80.4%, dia-
etic vs nondiabetic patients, respectively). At our institu-
ion, 4 consultants perform OPCAB surgery. Overall, the
ABLE 1. Baseline characteristics (n  5259)
ariable Diabetic (n  877)
ge (y) 64 (57-70)
ody mass index (m2) 27.5 (25.3-31.1)
emale sex 221
yspnea class
NYHA I and II 485
NYHA III and IV 392
anadian Cardiovascular
core
CCS 0 25
CCS 1-2 266
CCS 3-4 586
ongestive heart failure 150
revious myocardial infarction 410
ypertension 615
ypercholestrolemic 659
urrent smoker 83
enal failure 33
rrhythmia 52
eft main stem 50% stenosis 104
xtent of coronary disease
1-2 vessel 217
3 vessel 649
jection fraction
50% 575
30%-50% 225
30% 72
rgent operation 399
YHA, New York Heart Association; CCS, Canadian Cardiovascular Sociese of OPCAB surgery among these 4 surgeons ranged from t
04 The Journal of Thoracic and Cardiovascular Surgery ● Octo.
-
6% to 89%, but in the more recent era (2000 onward) all
arried out 70% or more of their operations off-pump.
either the distribution of coronary disease nor the diabetic
tatus is a factor that influences the decision to use OPCAB
urgery.
The observed in-hospital mortality rate was 2.3% and 1%
n the diabetic and nondiabetic groups, respectively. The
ncidence of in-hospital neurologic complications was 4.8%
nd 2.2% and that of infective complications was 4% and
.6% in the diabetic and nondiabetic patients, respectively.
his included infections of the sternum, conduit donor site,
nd episodes of septicemia (source known or unknown).
Table 3 shows the risk factors for in-hospital morta
he presence of diabetes mellitus was not found to be an
ndependent predictor of in-hospital mortality on multivar-
ate analysis (P  .089). On the contrary, age older than 65
ears, female sex, history of congestive heart failure, renal
ailure, ejection fraction less than 50%, left main stem
isease, and urgent operation were independent predictors
f in-hospital death.
Overall, OPCAB surgery had no significant associa-
.7) Nondiabetic (n  4382) % (83.3) P value
64 (58-70) .66
27.0 (24.7-29.4) .001
) 795 (18.1) .001
) 2933 (66.9) .001
) 1449 (33.1)
72 (1.6) .001
) 1664 (38.0)
) 2646 (60.4)
) 418 (9.5) .001
) 1866 (42.6) .023
) 2434 (55.6) .001
) 3291 (75.4) .87
569 (13.0) .015
81 (1.9) .001
178 (4.1) .014
) 582 (16.1) .30
) 1440 (33.4) .001
) 2870 (66.6)
) 3155 (72.3) .001
) 1006 (23.0)
207 (4.7)
) 1844 (42.2) .057% (16
(25.2
(55.3
(44.7
(2.9)
(30.3
(66.8
(17.1
(46.8
(70.2
(75.1
(9.5)
(3.8)
(5.9)
(14.6
(25.1
(75.0
(65.9
(25.8
(8.3)
(45.7ion with in-hospital mortality (odds ratio [OR]  0.99;
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CD5% confidence interval [CI] 0.56-1.71; P  .96) on
ultivariate analysis, and there was no evidence to sug-
est that the impact of OPCAB surgery on in-hospital
ortality differed between diabetic and nondiabetic pa-
ients (P  .41).
Table 4 shows the effect of diabetes on nonfatal 
omes. After adjustment for differences in prognostic vari-
bles, diabetic patients had a significantly higher chance of
aving neurologic, renal, and gastrointestinal complications
fter CABG surgery. OPCAB surgery was found to be
ssociated with fewer neurologic complications (OR  0.58;
5% CI 0.38-0.89; P  .012), but not renal complications
P  .18) or gastrointestinal complications (P  .82) on
ultivariate analysis. For all in-hospital outcomes, including
ortality, the outcome for patients with insulin-dependent di-
betes was similar to that for diabetic patients not dependent
ABLE 2. Operative and postoperative outcomes
ariable Diabetic (
n-hospital deaths 1
ff-pump 29
istal anastomosis (mean  SD) 2.8 (
omplete revascularization 66
se of left internal thoracic artery 78
se of a second arterial conduit 15
erioperative myocardial infarction 2
ostoperative atrial fibrillation 13
ulmonary complications 12
Chest infection 4
eurologic complications 4
nfective complications 3
Major infection of sternum requiring rewiring
Minor infection of sternum
Leg wound infection
Septicemia (source any/unknown) 1
Other infections
enal complications 5
astrointestinal complications 1
ultisystem failure 1
eoperation for bleeding/tamponade 2
lood transfusion*
Patients 32
Units 2 (1
resh frozen plasma*
Patients 6
Units 4 (2
latelets*
Patients 9
Units 1 (1
TU stay (d) 1 (1
ostop stay (d) 7 (6
D, Standard deviation; ITU, intensive treatment unit. *Transfusion details
atients).n insulin (P  .17). a
The Journal of Thoracic-
idterm Clinical Outcomes
verall, 99% of the study cohort was successfully matched
o the NSTS database. The remaining patients were cen-
ored at hospital discharge. Median follow-up was 3 years
n both groups. Diabetic patients had a significantly lower
-year survival than did nondiabetic patients (adjusted
azard ratio [HR]  1.55; 95% CI 1.22-1.96; P  .001)
Figure 1). Other patient factors identified as independe
redictors of 5-year all-cause mortality were advanced age
65 years), renal failure, preoperative arrhythmias, ejec-
ion fraction less than 50%, left main stem disease, ad-
anced Canadian Cardiovascular Society class, the presence
f congestive heart failure, and smoking less than 1 month
efore surgery (P  .032).
Follow-up data were available for 80% of eligible pa-
ients. Of the remaining 20%, 1% have indicated that they
77) % (16.7) Nondiabetic (n  4382) % (83.3)
(2.2) 45 (1.0)
(33.5) 1370 (31.3)
2.7 (0.9)
(75.9) 3521 (80.4)
(89.1) 4022 (91.8)
(17.2) 1043 (23.8)
(2.3) 94 (2.2)
(15.4) 571 (13.0)
(14.1) 544 (12.4)
(5.1) 228 (5.2)
(4.8) 94 (2.2)
(4.0) 115 (2.6)
(1.0) 31 (0.7)
(0.6) 22 (0.5)
(0.7) 20 (0.5)
(1.6) 48 (1.1)
(0.3) 6 (0.1)
(6.2) 143 (3.3)
(2.1) 43 (1.0)
(1.3) 27 (0.6)
(3.0) 167 (3.8)
(37.3) 1509 (34.4)
2 (1-3)
(7.0) 410 (9.4)
4 (2-4)
(10.3) 555 (12.7)
1 (1-2)
1 (1-1)
6 (5-8)
recorded before April 1997 (n  4520, 768 diabetic and 3752 nondiabeticn  8
9
4
0.8)
6
1
1
0
5
4
4
2
5
8
5
6
4
3
4
8
1
6
7
-3)
1
-4)
0
-2)
-2)
-9)
notre unable or unwilling to participate, 4.7% have since died,
and Cardiovascular Surgery ● Volume 132, Number 4 805
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CDnd the remainder remain lost to follow-up. The cumulative
ncidence of one or more cardiac-related events is shown in
igure 2. The cumulative incidence was similar at 1 ye
oth nondiabetic and diabetic patients (8.6% and 7.0%,
espectively). Thereafter, the curves separate with a marked
ncrease in incidence in the diabetic group between years 1
nd 2 postoperatively. The cumulative incidence at 2 years
as 15.0% (95% CI 13.8%-16.3%) and 21.8% (95% CI
8.7%-25.3%) in nondiabetic and diabetic patients, respec-
ively; subsequently the curves follow an almost parallel
ourse. At 5 years, 48% of diabetic patients versus 60% of
ABLE 4. The effect of diabetes on clinical outcomes
utcome
Adjusted* effect size
OR 95% CI P value
n-hospital death 1.63 0.92-2.88 .089
yocardial infarction 1.03 0.63-1.70 .899
trial fibrillation 1.10 0.89-1.37 .360
hest infection 0.91 0.65-1.28 .602
eurologic complications 2.01 1.37-2.96 .001
nfective complications 1.27 0.85-1.91 .238
enal complications 1.63 1.17-2.29 .004
astrointestinal
complications
1.76 0.99-3.12 .054
ultisystem failure 1.56 0.75-3.23 .234
R, Odds ratio; CI, confidence interval. *Adjusted for age, sex, body mass
ndex, New York Heart Association status, Canadian Cardiovascular Soci-
ty group, history of congestive heart failure, smoking status, preoperative
yocardial infarction, renal failure, arrhythmias, left main stem disease,
jection fraction, urgent operation, hypertension, extent of coronary dis-
ABLE 3. Predictors of in-hospital mortality
ariable
Univar
OR (95% CI)
ge 65 y 2.56 (1.51-4.32)
MI 35 (m2) 0.79 (0.19-3.27)
iabetes 2.13 (1.24-3.67)
YHA III and IV 2.94 (1.78-4.87)
CS 3 and 4 2.48 (1.34-4.58)
ongestive heart failure 4.79 (2.85-8.04)
urrent smoker 1.24 (0.68-2.25)
revious myocardial infarction 1.32 (0.80-2.15)
enal failure 4.87 (2.06-11.5)
rrhythmia 2.74 (1.23-6.07)
jection fraction 50% 3.70 (2.24-6.11)
rgent 3.00 (1.76-5.10)
emale sex 2.54 (1.53-4.24)
riple vessel disease 1.25 (0.72-2.20)
eft main stem disease 2.53 (1.39-4.62)
ypertension 2.01 (1.15-3.51)
ff-pump surgery 1.06 (0.62-1.78)
R, Odds ratio; CI, confidence interval; BMI, body mass index; NYHA, NeCase, and off-pump surgery.
06 The Journal of Thoracic and Cardiovascular Surgery ● Octor
ondiabetic patients were free of any cardiac-related event.
he incidence of one or more cardiac-related events over
ime was significantly higher for patients with diabetes, both
n univariate analysis (HR  1.44; 95% CI 1.26-1.64;
 .001) and on multivariate modeling (adjusted HR 
.24; 95% CI 1.08-1.42; P  .002). However, the incidence
f patient-reported hospital attendance for myocardial in-
arction, congestive heart failure, and/or further coronary
evascularization (main adverse coronary events) was sim-
lar at 5 years, when 5.9% (95% CI 4.9%-6.9%) of nondi-
betic patients had experienced one or more main adverse
oronary events compared with 6.9% (95% CI 4.8%-10.0%)
f diabetic patients (unadjusted P  .23; adjusted P  .76).
iscussion
here are several main findings from this study. The in-
ospital mortality in the diabetic patients was low (2.2%).
iabetes mellitus was not an independent predictor of in-
ospital mortality. The presence of diabetes mellitus was a
trong independent risk factor for neurologic and renal
omplications, but not for infective complications. Diabetes
as associated with a significantly higher incidence of late
ortality and cardiac-related events.
The in-hospital mortality in our study for diabetic pa-
ients compared favorably with the literature, despite the
orsening of case-mix in the current surgical era (over the
eriod of this study the median Parsonnet risk score in-
reased from 4 to 6 and the numbers of older patients and of
iabetic patients treated increased). Thourani and associ-
tes9 reported on 2278 diabetic patients who underw
Multivariate
P value OR (95% CI) P value
.001 1.69 (0.97-2.94) .060
.573 0.48 (0.11-2.08) .330
.006 1.63 (0.92-2.88) .089
.001 1.50 (0.85-2.64) .159
.004 1.20 (0.61-2.35) .590
.001 2.16 (1.20-3.87) .010
.477 1.56 (0.82-2.94) .171
.276 0.82 (0.48-1.42) .488
.001 2.61 (1.05-6.49) .038
.013 1.66 (0.71-3.83) .238
.001 2.55 (1.43-4.53) .001
.001 1.85 (1.05-3.27) .034
.001 2.40 (1.36-4.23) .003
.423 0.85 (0.47-1.53) .590
.002 2.03 (1.08-3.80) .028
.014 1.60 (0.90-2.83) .107
.839 0.99 (0.56-1.71) .959
k Heart Association; CCS, Canadian Cardiovascular Society.iateABG surgery from 1978 to 1993 with an observed mor-
ber 2006
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CDality of 3.9% and found diabetes to be an independent
redictor of in-hospital mortality. Several other studies in
he late 1980s had similar findings, reporting mortality rates
s high as 5%.4,7,8 North American multicenter registry da
n 41,663 diabetic patients who underwent CABG surgery
n 1997 reported a 30-day mortality of 3.7%.6 Two recent
tudies by Szabo,19 Kubal,20 and their associates (similar 
ur study period) agreed with our findings, reporting mor-
alities of 2.6% and 2.4% for their diabetic populations,
espectively. The older series are not contemporary with
espect to internal thoracic artery use, which was less than
0%, and modern perfusion and anesthetic techniques. The
orth American series did not specify blood glucose man-
gement in the perioperative period, which is now recog-
ized to lead to a better outcome.21 In contrast, this stud
nd both contemporary series mentioned previously had a strict
ostoperative glucose management protocol. Over 30% of our
atients in both groups underwent revascularization without
he use of cardiopulmonary bypass. The use of OPCAB
Figure 1. Kaplan-Meier surviurgery was based on surgeon preference, and it did not v
The Journal of Thoracicepend on either the preoperative diabetic status or the
istribution of coronary disease. OPCAB surgery was asso-
iated with fewer neurologic complications (P  .012) but
id not affect the incidence of renal complications (P 
18). Magee and colleagues22 compared diabetic and non-
iabetic patients who underwent OPCAB surgery and
howed a lower observed mortality for diabetic patients and
n even lower observed mortality for nondiabetic patients
ompared with the on-pump group, although this did not
ranslate as a significant benefit for diabetic patients after
isk adjustment. Similarly, Kubal and colleagues20 used
PCAB surgical technique in 21.7% of diabetic patients
nd had the lowest reported mortality rate of 2.4% for a
iabetic series to date.
After adjustment for differences in risk profile between
iabetic and nondiabetic patients, renal, neurologic and gastro-
ntestinal complications showed significant effect sizes. These
isks might be minimized by more thoughtful management,
or example, with specific attention to preoperative nonin-
5 years by diabetic status.val toasive vascular evaluation of carotid and renal arteries,
and Cardiovascular Surgery ● Volume 132, Number 4 807
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A
CDlimination or minimization of intraoperative aortic manip-
lation, preoperative volume replacement, and the timing of
ngiotensin-converting enzyme inhibitor therapy in patients
ith preoperative renal insufficiency.
Previous reports in the literature generally report an
ncreased short-term mortality and morbidity in CABG pa-
ients, which includes cardiovascular, infective, and respi-
atory complications.6,9,20 Whereas in our study the prob-
ility of an increased risk of in-hospital death for patients
ith diabetes mellitus was greater than .05, a 63% increased
isk was observed, which could occur by chance in around
0% of studies (P .092). The 95% CI further suggests that
he true in-hospital mortality risk could be as much as 187%
igher for a diabetic compared with a nondiabetic patient.
ith a 17% prevalence of diabetes in our population and a
ow 1% in-hospital mortality rate among nondiabetic pa-
ients, a study of more than 16,000 patients would be needed
o identify a 63% rise in mortality risk for persons with
Figure 2. Five-year cumulative incideniabetes as statistically significant with 80% power. a
08 The Journal of Thoracic and Cardiovascular Surgery ● OctoThe predisposition of diabetic patients to infective compli-
ations after cardiac surgery has been often suggested.6,23-27
e did not find an independent association between diabe-
es and infective complications (OR  1.27; 95% CI 0.85-
.91; P .24). Angiopathy, neuropathy, and hyperglycemia
ssociated with diabetes are identified as the main reasons
or predisposition to infections.28 Impaired host defense mech-
nisms such as impaired wound healing, impaired granulocyte
unction, decreased cellular immunity, impaired complement
unction, and decreased lymphokine response may be influ-
nced by glycemic control.28-30 Our results might be due 
he active control of blood glucose in diabetic patients with
nsulin infusion during the early postoperative period.
thers have suggested that this reduces mortality and
omplications.21,26,31,32 Controlling blood glucose leve
t less than 11.1 mmol/L (200 mg/dL) in diabetic patients
eads to significantly fewer postoperative complications,
ncluding in-hospital death.24,25,33 Furthermore, Fish and
f cardiac-related events on follow-up.ce ossociates25 found that, in diabetic patients, a blood glucose
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A
CDevel less than 11.1 mmol/L carried a 36% higher risk and a
lood glucose level of 13.9 mmol/L or more carried a 63%
igher risk of infective complications.
Diabetes was found to be an independent predictor of
-year mortality and lower cardiac event-free survival, de-
pite key patient risk factors, including diabetes, hyperten-
ion, and hypercholesterolemia being managed in the long-
erm by the family physician and cardiologist. However, we
annot provide data on the long-term management of other
actors that could potentially influence late mortality and
ardiac event-free survival, such as obesity and lack of
xercise. This finding is in keeping with the other reports in
he literature.6,9,19,34-36 The negative impact of diabet
ellitus on long-term outcome is probably influenced by
everal factors. First are the end-organ effects of diabetes
nd the influence of the insulin-resistant syndrome on the
rogression of comorbidities. Second is the presence of
ore complex diffuse coronary artery disease. Third is the
apid progression of coronary artery disease and occurrence
f new atherosclerotic lesions in the native vessels in diabetic
atients with insulin-resistant syndrome. Fourth, type-2 diabe-
es mellitus in particular affects the morphology of the
ypass conduits and may be a factor in late conduit failure.
imilar to our study on follow-up, Thourani and associ9
ound no difference in the incidence of myocardial infarc-
ion and need for reintervention up to 10 years after CABG.
Historically, surgery has been considered the treatment
f choice for diabetic patients with multivessel coronary
isease.5 More recently, there has been the advent of d
luting stents, and several trials are ongoing to assess the
mpact of this technique for diabetic patients.37
The limitation of this study is that it was a retrospective
nalysis, although the data were collected prospectively. At
he time of data collection, this analysis had not been
lanned. It is possible that the differences or similarities
bserved between the groups were a result of unforeseen
onfounders. However, multivariate analysis is a theoreti-
ally sound statistical method of accounting for differences
etween groups in the absence of random allocation. Also,
his study was based on a large cohort of patients from a
ingle institution, which adds to the power of these results.
In conclusion, despite the worsening case-mix, the early
ortality and morbidity of diabetic patients undergoing
ABG surgery has significantly improved and is compara-
le with those of nondiabetic patients. These improvements
ould be due to modern surgical, anesthetic, and cardopul-
onary techniques, as well as to postoperative blood glu-
ose management strategies.
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